Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
UL54
Description:
A cytomegalovirus gene encoding the viral DNA polymerase, studied in antiviral drug resistance and viral genetics.
Primary topic:
Cytomegalovirus and herpesvirus research (79%)
Related topics:
Cytomegalovirus and herpesvirus research (79%),
Herpesvirus Infections and Treatments (13%)
OpenAlex ID:
keywords/ul54
High‐Level Resistance of Cytomegalovirus to Ganciclovir Is Associated with Alterations in Both the UL97 and DNA Polymerase Genes
1997
·
Irene L. Smith
, Julie M. Cherrington
, et al.
·
The Journal of Infectious Diseases
·
282
Absence of Cytomegalovirus‐Resistance Mutations after Valganciclovir Prophylaxis, in a Prospective Multicenter Study of Solid‐Organ Transplant Recipients
2004
·
Guy Boivin
, Nathalie Goyette
, et al.
·
The Journal of Infectious Diseases
·
170
Characterization of Drug Resistance-Associated Mutations in the Human Cytomegalovirus DNA Polymerase Gene by Using Recombinant Mutant Viruses Generated from Overlapping DNA Fragments
1998
·
Tomas Cihlar
, Michael D. Fuller
, et al.
·
Journal of Virology
·
166
Global Analysis of Herpes Simplex Virus Type 1 Transcription Using an Oligonucleotide-Based DNA Microarray
2000
·
S. W. Stingley
, J. J. Garcia Ramirez
, et al.
·
Journal of Virology
·
153
Detection of Cytomegalovirus Drug Resistance Mutations by Next-Generation Sequencing
2013
·
Malaya K. Sahoo
, Martina I. Lefterova
, et al.
·
Journal of Clinical Microbiology
·
127
PDF
Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir
2009
·
Guy Boivin
, Nathalie Goyette
, et al.
·
Antiviral Therapy
·
116
PDF
Genomic Signature of the Natural Oncolytic Herpes Simplex Virus HF10 and Its Therapeutic Role in Preclinical and Clinical Trials
2017
·
Ibrahim Ragab Eissa
, Yoshinori Naoe
, et al.
·
Frontiers in Oncology
·
108
PDF
Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes
2000
·
Tobias Eckle
, Lothar Prix
, et al.
·
Blood
·
105
Drug Resistance Mutations and Associated Phenotypes Detected in Clinical Trials of Maribavir for Treatment of Cytomegalovirus Infection
2020
·
Sunwen Chou
, Kening Song
, et al.
·
The Journal of Infectious Diseases
·
94
PDF
Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients
2023
·
Sunwen Chou
, Sophie Alain
, et al.
·
The Journal of Infectious Diseases
·
93
PDF
Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs
2004
·
Fausto Baldanti
, Nell Lurain
, et al.
·
Human Immunology
·
88
Detection of Low Frequency Multi-Drug Resistance and Novel Putative Maribavir Resistance in Immunocompromised Pediatric Patients with Cytomegalovirus
2016
·
Charlotte Houldcroft
, Josephine M. Bryant
, et al.
·
Frontiers in Microbiology
·
85
PDF
Residues of Human Cytomegalovirus DNA Polymerase Catalytic Subunit UL54 That Are Necessary and Sufficient for Interaction with the Accessory Protein UL44
2003
·
Arianna Loregian
, Brent A. Appleton
, et al.
·
Journal of Virology
·
84
Multiple regulatory events influence human cytomegalovirus DNA polymerase (UL54) expression during viral infection
1996
·
J A Kerry
, M A Priddy
, et al.
·
Journal of Virology
·
82
Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients
2002
·
Dana G. Wolf
, Nell S. Lurain
, et al.
·
Blood
·
73
Construction of a rationally designed human cytomegalovirus variant encoding a temperature-sensitive immediate-early 2 protein
2002
·
Julie A. Heider
, Wade A. Bresnahan
, et al.
·
Proceedings of the National Academy of Sciences
·
68
Crystal Structure of the Cytomegalovirus DNA Polymerase Subunit UL44 in Complex with the C Terminus from the Catalytic Subunit
2005
·
Brent A. Appleton
, Justin Brooks
, et al.
·
Journal of Biological Chemistry
·
67
PDF
Analysis of cytomegalovirus DNA polymerase (UL54) mutations in solid organ transplant patients receiving valganciclovir or ganciclovir prophylaxis
2005
·
Guy Boivin
, Nathalie Goyette
, et al.
·
Journal of Medical Virology
·
67
Specific Residues in the Connector Loop of the Human Cytomegalovirus DNA Polymerase Accessory Protein UL44 Are Crucial for Interaction with the UL54 Catalytic Subunit
2004
·
Arianna Loregian
, Brent A. Appleton
, et al.
·
Journal of Virology
·
63
Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity
2001
·
Mehrdad Mousavi-Jazi
, Lottie Schloss
, et al.
·
Journal of Clinical Virology
·
62
Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients
2008
·
Sonali K. Sanghavi
, Kareem Abu-Elmagd
, et al.
·
Journal of Clinical Virology
·
61
Incidence of cytomegalovirus UL97 and UL54 amino acid substitutions detected after 100 or 200 days of valganciclovir prophylaxis
2012
·
Guy Boivin
, Nathalie Goyette
, et al.
·
Journal of Clinical Virology
·
59
Identification of sequence elements in the human cytomegalovirus DNA polymerase gene promoter required for activation by viral gene products
1994
·
J A Kerry
, M A Priddy
, et al.
·
Journal of Virology
·
59
Inhibition of Human Cytomegalovirus DNA Polymerase by C-Terminal Peptides from the UL54 Subunit
2003
·
Arianna Loregian
, Roberto Rigatti
, et al.
·
Journal of Virology
·
56
Antiviral Drug- and Multidrug Resistance in Cytomegalovirus Infected SCT Patients
2015
·
Katharina Göhring
, Klaus Hamprecht
, et al.
·
Computational and Structural Biotechnology Journal
·
52
PDF
Show more works
View as search
Works count:
166
Citation count:
4,073
Year
Topic
Type